Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

[Mycophenolate mofetil in refractory Crohn's disease after failure of treatments by azathioprine or methotrexate].

Hafraoui S, Dewit O, Marteau P, Cosnes J, Colombel JF, Modigliani R, Cortot A, Lémann M.

Gastroenterol Clin Biol. 2002 Jan;26(1):17-22. French.

2.

Is mycophenolate mofetil an effective alternative in azathioprine-intolerant patients with chronic active Crohn's disease?

Miehsler W, Reinisch W, Moser G, Gangl A, Vogelsang H.

Am J Gastroenterol. 2001 Mar;96(3):782-7.

PMID:
11280551
3.

Efficacy of mycophenolate mofetil in patients failing 6-mercaptopurine or azathioprine therapy for Crohn's disease.

Hassard PV, Vasiliauskas EA, Kam LY, Targan SR, Abreu MT.

Inflamm Bowel Dis. 2000 Feb;6(1):16-20.

PMID:
10701145
4.

Mycophenolate mofetil, azathioprine and methotrexate usage in paediatric anti-NMDAR encephalitis: A systematic literature review.

Nosadini M, Mohammad SS, Toldo I, Sartori S, Dale RC.

Eur J Paediatr Neurol. 2019 Jan;23(1):7-18. doi: 10.1016/j.ejpn.2018.09.008. Epub 2018 Sep 27.

PMID:
30318435
5.

Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12-month pilot study.

Orth T, Peters M, Schlaak JF, Krummenauer F, Wanitschke R, Mayet WJ, Galle PR, Neurath MF.

Am J Gastroenterol. 2000 May;95(5):1201-7.

PMID:
10811328
6.

Efficacy of methotrexate in pediatric Crohn's disease: a French multicenter study.

Uhlen S, Belbouab R, Narebski K, Goulet O, Schmitz J, Cézard JP, Turck D, Ruemmele FM.

Inflamm Bowel Dis. 2006 Nov;12(11):1053-7.

PMID:
17075346
7.

Mycophenolate mofetil for Crohn's disease: short-term efficacy and long-term outcome.

Wenzl HH, Hinterleitner TA, Aichbichler BW, Fickert P, Petritsch W.

Aliment Pharmacol Ther. 2004 Feb 15;19(4):427-34.

8.

Mycophenolate mofetil in patients with Crohn's disease.

Fickert P, Hinterleitner TA, Wenzl HH, Aichbichler BW, Petritsch W.

Am J Gastroenterol. 1998 Dec;93(12):2529-32.

PMID:
9860419
9.

Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues.

Weiss B, Lerner A, Shapiro R, Broide E, Levine A, Fradkin A, Bujanover Y.

J Pediatr Gastroenterol Nutr. 2009 May;48(5):526-30. doi: 10.1097/MPG.0b013e318196df3e.

PMID:
19412004
10.

Use of mycophenolate mofetil in inflammatory bowel disease.

Tan T, Lawrance IC.

World J Gastroenterol. 2009 Apr 7;15(13):1594-9.

11.

Mycophenolate mofetil therapy for refractory inflammatory bowel disease.

Palaniappan S, Ford AC, Greer D, Everett SM, Chalmers DM, Axon AT, Hamlin PJ.

Inflamm Bowel Dis. 2007 Dec;13(12):1488-92.

PMID:
17924566
12.

Use of Mycophenolate Mofetil in Patients with Severe Localized Scleroderma Resistant or Intolerant to Methotrexate.

Mertens JS, Marsman D, van de Kerkhof PC, Hoppenreijs EP, Knaapen HK, Radstake TR, de Jong EM, Seyger MM.

Acta Derm Venereol. 2016 May;96(4):510-3. doi: 10.2340/00015555-2297.

14.

Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.

[No authors listed]

Transplantation. 1998 Jan 27;65(2):235-41. Erratum in: Transplantation 1998 Apr 15;65(7):followi.

PMID:
9458021
15.

Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease.

Neurath MF, Wanitschke R, Peters M, Krummenauer F, Meyer zum Büschenfelde KH, Schlaak JF.

Gut. 1999 May;44(5):625-8.

16.

Mycophenolate mofetil therapy in the management of inflammatory bowel disease--a retrospective case series and review.

Smith MR, Cooper SC.

J Crohns Colitis. 2014 Aug;8(8):890-7. doi: 10.1016/j.crohns.2014.01.014. Epub 2014 Feb 4. Review.

PMID:
24507162
17.

The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes.

Baven-Pronk AM, Coenraad MJ, van Buuren HR, de Man RA, van Erpecum KJ, Lamers MM, Drenth JP, van den Berg AP, Beuers UH, den Ouden J, Koek GH, van Nieuwkerk CM, Bouma G, Brouwer JT, van Hoek B.

Aliment Pharmacol Ther. 2011 Aug;34(3):335-43. doi: 10.1111/j.1365-2036.2011.04727.x. Epub 2011 Jun 12.

18.

Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis.

Chan TM, Tse KC, Tang CS, Mok MY, Li FK; Hong Kong Nephrology Study Group.

J Am Soc Nephrol. 2005 Apr;16(4):1076-84. Epub 2005 Feb 23.

19.

Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis.

Sobrin L, Christen W, Foster CS.

Ophthalmology. 2008 Aug;115(8):1416-21, 1421.e1. doi: 10.1016/j.ophtha.2007.12.011. Epub 2008 Jan 25.

PMID:
18221998
20.

Safety of mycophenolate mofetil versus azathioprine in renal transplantation: a systematic review.

Wang K, Zhang H, Li Y, Wei Q, Li H, Yang Y, Lu Y.

Transplant Proc. 2004 Sep;36(7):2068-70. Review.

PMID:
15518748

Supplemental Content

Support Center